Furthermore, CXCL12—a chemokine 12 able to bind to its cognate receptor CXCR4 determining the activation of several downstream signaling pathways which regulate tumor progression and metastasis—was found to be significantly downregulated in all the case series. Here, CXCL12 is linked to neoplasm.